|
WO2020130672A1
|
|
Purification method for vaccine virus using affinity chromatography
|
|
KR20190120112A
|
|
Intermediates of chiral piperidine derivatives and preparation method thereof
|
|
KR20190096917A
|
|
Heterocylic compound as a protein kinase inhibitor
|
|
KR20190064555A
|
|
Heterocylic compound as a protein kinase inhibitor
|
|
WO2018216978A1
|
|
Cell culture method at low temperature applicable to mass production of protein
|
|
KR20180127930A
|
|
Cell culture method at low temperature applicable to mass production of protein
|
|
WO2018212556A1
|
|
A method for purifying an antibody or an antibody fragment thereof using affinity chromatography
|
|
KR20180125899A
|
|
A method for purifying an antibody fragment or antibody using affinity chromatography
|
|
KR20190130432A
|
|
Pharmaceutical Composition comprising SGLT-2 inhibitor and DPP-IV inhibitor
|
|
KR20180050639A
|
|
Stable pharmaceutical composition comprising solifenacin, and method for preparing the same
|
|
KR102024308B1
|
|
Port for medical solution bag
|
|
KR20180116159A
|
|
Method of Purifying Analogous Antibody Using Cation Exchange Chromatography
|
|
KR20180011830A
|
|
New method for preparation of chromanone derivatives
|
|
KR20190068946A
|
|
Intermediates of chiral piperidine derivatives and preparation method thereof
|
|
TW201924677A
|
|
Use of benzimidazole derivatives for nocturnal acid breakthrough
|
|
KR20190045685A
|
|
An extract of Coptidis Rhizoma prepared with water-swelling
|
|
KR20190043437A
|
|
Heterocylic compound as a protein kinase inhibitor
|
|
KR20190023236A
|
|
An extract of Coptidis Rhizoma extracted with acetone, or a mixture of acetone and water
|
|
KR20190022058A
|
|
medical solution bag
|
|
KR20190022057A
|
|
medical solution bag
|
